{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T18:36:09Z","timestamp":1791916569645,"version":"4.3.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2012,4,29]],"date-time":"2012-04-29T00:00:00Z","timestamp":1335657600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1007\/s00277-012-1469-3","type":"journal-article","created":{"date-parts":[[2012,4,28]],"date-time":"2012-04-28T12:33:10Z","timestamp":1335616390000},"page":"1393-1401","source":"Crossref","is-referenced-by-count":25,"title":["Ophthalmologic outcomes after chemotherapy and\/or radiotherapy in non-conjunctival ocular adnexal MALT lymphoma"],"prefix":"10.1007","volume":"91","author":[{"given":"Ji-Sun","family":"Paik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won-Kyung","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Eun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung-Ock","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Eun","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyeong-Sin","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suk-Woo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok-Goo","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,4,29]]},"reference":[{"key":"1469_CR1","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1002\/1097-0142(19940501)73:9<2395::AID-CNCR2820730924>3.0.CO;2-V","volume":"73","author":"O Bairey","year":"1994","unstructured":"Bairey O, Kremer I, Rakowsky E, Hadar H, Shaklai M (1994) Orbital and adnexal involvement in systemic non-Hodgkin\u2019s lymphoma. Cancer 73:2395\u20132399","journal-title":"Cancer"},{"key":"1469_CR2","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/1097-0142(197201)29:1<252::AID-CNCR2820290138>3.0.CO;2-#","volume":"29","author":"C Freeman","year":"1972","unstructured":"Freeman C, Berg J, Cutler S (1972) Occurrence and prognosis of extranodal lymphomas. Cancer 29:252\u2013260","journal-title":"Cancer"},{"key":"1469_CR3","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1016\/S0161-6420(95)30764-6","volume":"102","author":"WL White","year":"1995","unstructured":"White WL, Ferry JA, Harris NL, Grove AS Jr (1995) Ocular adnexal lymphoma: a clinicopathologic study with identification of lymphomas of mucosa-associated lymphoid tissue (MALT) type. Ophthalmology 102:1994\u20132006","journal-title":"Ophthalmology"},{"key":"1469_CR4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10384-004-0147-y","volume":"49","author":"K Ohtsuka","year":"2005","unstructured":"Ohtsuka K, Hashimoto M, Suzuki Y (2005) A review of 244 orbital tumors in Japanese patients during a 21-year period: origins and locations. Jpn J Ophthalmol 49:49\u201355","journal-title":"Jpn J Ophthalmol"},{"key":"1469_CR5","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/S0360-3016(03)00767-3","volume":"57","author":"CY Fung","year":"2003","unstructured":"Fung CY, Tarbell NJ, Lucarelli MJ, Goldberg SI, Linggood RM, Harris NL, Ferry JA (2003) Ocular adnexal lymphoma: clinical behavior or distinct World Health Organization classification subtypes. Int J Radiat Oncol Biol Phys 57:1382\u20131391","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1469_CR6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/ajh.10332","volume":"73","author":"EY Cho","year":"2003","unstructured":"Cho EY, Han JJ, Ree HJ, Ko YH, Kang YK, Ahn HS, Park CJ, Huh J (2003) Clinicopathologic analysis of ocular adnexal lymphomas: extranodal marginal zone B-cell lymphoma constitutes the vast majority of ocular lymphomas among Korean and affects younger patients. Am J Hematol 73:87\u201396","journal-title":"Am J Hematol"},{"key":"1469_CR7","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0360-3016(03)00506-6","volume":"57","author":"M Hasegawa","year":"2003","unstructured":"Hasegawa M, Kojima M, Shioya M, Tamaki Y, Saitoh J, Sakurai H, Kitamoto Y, Suzuki Y, Niibe H, Nakano T (2003) Treatment results of radiotherapy for malignant lymphoma of the orbit and histopathologic review according to the WHO classification. Int J Radiat Oncol Biol Phys 57:172\u2013176","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1469_CR8","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/cncr.11539","volume":"98","author":"T Uno","year":"2003","unstructured":"Uno T, Isobe K, Shikama N, Nishikawa A, Oguchi M, Ueno N, Itami J, Ohnishi H, Mikata A, Ito H (2003) Radiotherapy for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue originating in the ocular adnexa: a multiinstitutional, retrospective review of 50 patients. Cancer 98:865\u2013871","journal-title":"Cancer"},{"key":"1469_CR9","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1136\/bjo.83.6.742","volume":"83","author":"M Cahill","year":"1999","unstructured":"Cahill M, Barnes C, Moriarty P, Daly P, Kennedy S (1999) Ocular adnexal lymphoma\u2014comparison of MALT lymphoma with other histologic types. Br J Ophthalmol 83:742\u2013747","journal-title":"Br J Ophthalmol"},{"key":"1469_CR10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00277-004-0914-3","volume":"84","author":"JL Lee","year":"2005","unstructured":"Lee JL, Kim MK, Lee KH, Hyun MS, Chung HS, Kim DS, Shin SO, Cho HS, Bae SH, Ryoo HM (2005) Extranodal marginal zone B-cell lymphomas of mucosa-associated lymphoid tissue-type of the orbit and ocular adnexa. Ann Hematol 84:13\u201318","journal-title":"Ann Hematol"},{"key":"1469_CR11","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1200\/JCO.2003.06.085","volume":"21","author":"RW Tsang","year":"2003","unstructured":"Tsang RW, Gospodarowicz MK, Pintilie M, Wells W, Hodgson DC, Sun A, Crump M, Patterson BJ (2003) Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome. J Clin Oncol 21:4157\u20134164","journal-title":"J Clin Oncol"},{"key":"1469_CR12","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.ophtha.2006.01.057","volume":"113","author":"GJ Ben Simon","year":"2006","unstructured":"Ben Simon GJ, Cheung N, McKelvie P, Fox R, McNab AA (2006) Oral chlorambucil for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue of the orbit. Ophthalmology 113:1209\u20131213","journal-title":"Ophthalmology"},{"key":"1469_CR13","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/annonc\/mdm457","volume":"19","author":"EK Song","year":"2008","unstructured":"Song EK, Kim SY, Kim TM, Lee KW, Yun T, Na II, Shin H, Lee SH, Kim DW, Khwarg SI, Heo DS (2008) Efficacy of chemotherapy as a first-line treatment in ocular adnexal extranodal marginal zone B-cell lymphoma. Ann Oncol 19:242\u2013246","journal-title":"Ann Oncol"},{"key":"1469_CR14","first-page":"1639","volume":"37","author":"H Kashiwagi","year":"2010","unstructured":"Kashiwagi H (2010) Ocular disorders of anticancer drugs\u2014ocular side effects. Gan To Kagaku Ryoho 37:1639\u20131644","journal-title":"Gan To Kagaku Ryoho"},{"key":"1469_CR15","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/(SICI)1097-0142(19961001)78:7<1359::AID-CNCR1>3.0.CO;2-G","volume":"78","author":"T al-Tweigeri","year":"1996","unstructured":"al-Tweigeri T, Nabholtz JM, Mackey JR (1996) Ocular toxicity and cancer therapy. A review. Cancer 78:1359\u20131373","journal-title":"Cancer"},{"key":"1469_CR16","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/modpathol.3880366","volume":"14","author":"T Mannami","year":"2001","unstructured":"Mannami T, Yoshino T, Oshima K, Takase S, Kondo E, Ohara N, Nakagawa H, Ohtsuki H, Harada M, Akagi T (2001) Clinical, histopathological, and immunogenetic analysis of ocular adnexal lymphoproliferative disorders: characterization of MALT lymphoma and reactive lymphoid hyperplasia. Mod Pathol 14:641\u2013649","journal-title":"Mod Pathol"},{"key":"1469_CR17","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/IOP.0b013e318030b058","volume":"23","author":"JS Yoon","year":"2007","unstructured":"Yoon JS, Ma KT, Kim SJ, Kook K, Lee SY (2007) Prognosis for patients in a Korean population with ocular adnexal lymphoproliferative lesions. Ophthal Plast Reconstr Surg 23:94\u201399","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"1469_CR18","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1002\/cncr.11317","volume":"97","author":"C Wenzel","year":"2003","unstructured":"Wenzel C, Fiebiger W, Dieckmann K, Formanek M, Chott A (2003) Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue of the head and neck area: high rate of disease recurrence following local therapy. Cancer 97:2236\u20132241","journal-title":"Cancer"},{"key":"1469_CR19","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/jnci\/djj373","volume":"98","author":"AJ Ferreri","year":"2006","unstructured":"Ferreri AJ, Ponzoni M, Guidoboni M, Resti AG, Politi LS, Cortelazzo S, Demeter J, Zallio F, Palmas A, Muti G, Dognini GP, Pasini E, Lettini AA, Sacchetti F, De Conciliis C, Doglioni C, Dolcetti R (2006) Bacteria-eradicating therapy with doxycyclin in ocular adnexal MATL lymphoma: a multicenter prospective trial. J Natl Cancer Inst 98:1375\u20131382","journal-title":"J Natl Cancer Inst"},{"key":"1469_CR20","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1182\/blood-2008-12-195453","volume":"114","author":"A Stefanovic","year":"2009","unstructured":"Stefanovic A, Lossos IS (2009) Extranodal marginal zone lymphoma of the ocular adnexa. Blood 114:501\u2013510","journal-title":"Blood"},{"key":"1469_CR21","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/PAP.0b013e3181e4abdb","volume":"17","author":"PA McKelvie","year":"2010","unstructured":"McKelvie PA (2010) Ocular adenexal lymphoma: a review. Adv Anat Pathol 17:251\u2013261","journal-title":"Adv Anat Pathol"},{"key":"1469_CR22","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.radonc.2005.11.005","volume":"78","author":"Y Ejima","year":"2006","unstructured":"Ejima Y, Sasaki R, Okamoto Y, Maruta T, Azumi A, Hayashi Y, Demizu Y, Ota Y, Soejima T, Sugimura K (2006) Ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiotherapy. Radiother Oncol 78:6\u20139","journal-title":"Radiother Oncol"},{"key":"1469_CR23","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ijrobp.2005.11.035","volume":"65","author":"CO Suh","year":"2006","unstructured":"Suh CO, Shim SJ, Lee SW, Yang WI, Lee SY, Hahn JS (2006) Orbital marginal zone B-cell lymphoma of MALT: radiotherapy results and clinical behavior. Int J Radiat Oncol Biol Phys 65:228\u2013233","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1469_CR24","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/01.ico.0000214802.40313.fa","volume":"25","author":"A Behrens","year":"2006","unstructured":"Behrens A, Doyle JJ, Stern L, Chuck RS, McDonnell PJ, Azar DT, Dua HS, Hom M, Karpecki PM, Laibson PR, Lemp MA, Meisler DM, Del Castillo JM, O'Brien TP, Pflugfelder SC, Rolando M, Schein OD, Seitz B, Tseng SC, van Setten G, Wilson SE, Yiu SC, Dysfunctional tear syndrome study group (2006) Dysfunctional tear syndrome: a Delphi approach to treatment recommendations. Cornea 25:900\u2013907","journal-title":"Cornea"},{"key":"1469_CR25","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.5858\/133.8.1262","volume":"133","author":"SE Coupland","year":"2009","unstructured":"Coupland SE, White VA, Rootman J, Damato B, Finger PT (2009) A TNM-based clinical staging system of ocular adnexal lymphomas. Arch Pathol Lab Med 133:1262\u20131267","journal-title":"Arch Pathol Lab Med"},{"key":"1469_CR26","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/ajh.21963","volume":"86","author":"SE Lee","year":"2011","unstructured":"Lee SE, Paik JS, Cho WK, Choi BO, Lee SN, Jung SE, Park KS, Kang CS, Kim SH, Yang SW, Cho SG (2011) Feasibility of the TNM-based system of ocular adnexal extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). Am J Hematol 86:262\u2013266","journal-title":"Am J Hematol"},{"key":"1469_CR27","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1046\/j.1442-9071.2001.d01-18.x","volume":"29","author":"PA McKelvie","year":"2001","unstructured":"McKelvie PA, McNab A, Francis IC, Fox R, O\u2019Day J (2001) Ocular adnexal lymphoproliferative disease: a series of 73 cases. Clin Exp Ophthalmol 29:387\u2013393","journal-title":"Clin Exp Ophthalmol"},{"key":"1469_CR28","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1136\/bjo.2004.047092","volume":"89","author":"SE Coupland","year":"2005","unstructured":"Coupland SE, Hellmich M, Auw-Haedrich C, Lee WR, Anagnostopoulos I, Stein H (2005) Plasmacellular differentiation in extranodal marginal zone B cell lymphomas of the ocular adnexa: an analysis of the neoplastic plasma cell phenotype and its prognostic significance in 136 cases. Br J Ophthalmol 89:352\u2013359","journal-title":"Br J Ophthalmol"},{"key":"1469_CR29","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ajo.2006.10.044","volume":"143","author":"SC Kao","year":"2007","unstructured":"Kao SC, Kau HC, Tsai CC, Tsay SH, Yang CF, Wu JS, Hsu WM (2007) Lacrimal gland extranodal marginal zone B-cell lymphoma of MALT-type. Am J Ophthalmol 143:311\u2013316","journal-title":"Am J Ophthalmol"},{"key":"1469_CR30","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.radonc.2008.09.011","volume":"90","author":"H Nam","year":"2009","unstructured":"Nam H, Ahn YC, Kim YD, Ko Y, Kim WS (2009) Prognostic significance of anatomic subsites: results of radiation therapy for 66 patients with localized orbital marginal zone B cell lymphoma. Radiother Oncol 90:236\u2013241","journal-title":"Radiother Oncol"},{"key":"1469_CR31","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","volume":"25","author":"BD Cheson","year":"2007","unstructured":"Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ, Coiffier B, Fisher RI, Hagenbeek A, Zucca E, Rosen ST, Stroobants S, Lister TA, Hoppe RT, Dreyling M, Tobinai K, Vose JM, Connors JM, Federico M, Diehl V, International Harmonization Project on Lymphoma (2007) Revised response criteria for malignant lymphoma. J Clin Oncol 25:579\u2013586","journal-title":"J Clin Oncol"},{"key":"1469_CR32","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/annonc\/mdj025","volume":"17","author":"K Tanimoto","year":"2006","unstructured":"Tanimoto K, Kaneko A, Suzuki S, Sekiguchi N, Maruyama D, Kim SW, Watanabe T, Kobayashi Y, Kagami Y, Maeshima A, Matsuno Y, Tobinai K (2006) Long term follow-up results of no initial therapy for ocular adnexal MALT lymphoma. Ann Oncol 17:135\u2013140","journal-title":"Ann Oncol"},{"key":"1469_CR33","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/ICU.0b013e32830b1539","volume":"19","author":"D Shome","year":"2008","unstructured":"Shome D, Esmaeli B (2008) Targeted monoclonal antibody therapy and radioimmunotherapy for lymphoproliferative disorders of ocular adnexa. Curr Opin Ophthalmol 19:414\u2013421","journal-title":"Curr Opin Ophthalmol"},{"key":"1469_CR34","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00277-007-0301-y","volume":"86","author":"L Rigacci","year":"2007","unstructured":"Rigacci L, Nassi L, Puccioni M, Mappa S, Polito E, Dal Pozzo S, Alterini R, Carrai V, Puccini B, Bosi A (2007) Rituximab and chlorambucil as first-line treatment for low grade ocular adnexal lymphomas. Ann Hematol 86:565\u2013868","journal-title":"Ann Hematol"},{"key":"1469_CR35","doi-asserted-by":"crossref","unstructured":"Zucca E, Conconi A, Martinelli G et al. (2010) Chlorambucil plus rituximab produces better event-free survival in comparison with chlorambucil alone in the treatment of MALT lymphoma: 5-year analysis of the 2-arms part of the IELSG-19 randomized study. Blood. ASH Annual Meeting Abstracts 116:Abstract 432","DOI":"10.1182\/blood.V116.21.432.432"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-012-1469-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-012-1469-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-012-1469-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T11:45:50Z","timestamp":1642160750000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-012-1469-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,29]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["1469"],"URL":"https:\/\/doi.org\/10.1007\/s00277-012-1469-3","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,29]]}}}